Securities and Exchange Commission

Official Website: https://www.sec.gov/

REGENERON PHARMACEUTICALS, INC. — REGN

Company Profile SEC Filings Financial Statements

Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.

Compare To Other Companies

Annual (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
0 2014-02-13 10-K 2013 FY 2011-01-01 2011-12-31 CY2011
990,000 2015-02-12 10-K 2014 FY 2012-01-01 2012-12-31 CY2012
2,707,000 2016-02-11 10-K 2015 FY 2013-01-01 2013-12-31 CY2013
2,936,000 2017-02-09 10-K 2016 FY 2014-01-01 2014-12-31 CY2014
2,246,000 2018-02-08 10-K 2017 FY 2015-01-01 2015-12-31 CY2015
900,000 2019-02-07 10-K 2018 FY 2016-01-01 2016-12-31 CY2016
0 2019-02-07 10-K 2018 FY 2017-01-01 2017-12-31 CY2017
0 2019-02-07 10-K 2018 FY 2018-01-01 2018-12-31 CY2018

Quarterly (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
831,000 2013-08-06 10-Q 2013 Q2 2012-04-01 2012-06-30 CY2012Q2
1,154,000 2013-11-05 10-Q 2013 Q3 2012-07-01 2012-09-30 CY2012Q3
1,890,000 2014-05-08 10-Q 2014 Q1 2013-01-01 2013-03-31 CY2013Q1
2,645,000 2014-08-05 10-Q 2014 Q2 2013-04-01 2013-06-30 CY2013Q2
2,885,000 2014-11-04 10-Q 2014 Q3 2013-07-01 2013-09-30 CY2013Q3
3,162,000 2015-05-07 10-Q 2015 Q1 2014-01-01 2014-03-31 CY2014Q1
2,877,000 2015-08-04 10-Q 2015 Q2 2014-04-01 2014-06-30 CY2014Q2
2,787,000 2015-11-04 10-Q 2015 Q3 2014-07-01 2014-09-30 CY2014Q3
2,512,000 2016-05-05 10-Q 2016 Q1 2015-01-01 2015-03-31 CY2015Q1
2,461,000 2016-08-04 10-Q 2016 Q2 2015-04-01 2015-06-30 CY2015Q2
2,175,000 2016-11-04 10-Q 2016 Q3 2015-07-01 2015-09-30 CY2015Q3
1,278,000 2017-05-04 10-Q 2017 Q1 2016-01-01 2016-03-31 CY2016Q1
984,000 2017-08-03 10-Q 2017 Q2 2016-04-01 2016-06-30 CY2016Q2
998,000 2017-11-08 10-Q 2017 Q3 2016-07-01 2016-09-30 CY2016Q3
0 2017-05-04 10-Q 2017 Q1 2017-01-01 2017-03-31 CY2017Q1
0 2017-08-03 10-Q 2017 Q2 2017-04-01 2017-06-30 CY2017Q2
0 2017-11-08 10-Q 2017 Q3 2017-07-01 2017-09-30 CY2017Q3

All Reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants (shares)

Value Reported On Form FY FP Start Date End Date Fiscal Period
0 2014-02-13 10-K 2013 FY 2011-01-01 2011-12-31 CY2011
341,000 2012-07-25 10-Q 2012 Q2 2012-01-01 2012-06-30
341,000 2013-08-06 10-Q 2013 Q2 2012-01-01 2012-06-30
831,000 2012-07-25 10-Q 2012 Q2 2012-04-01 2012-06-30
831,000 2013-08-06 10-Q 2013 Q2 2012-04-01 2012-06-30 CY2012Q2
652,000 2012-10-24 10-Q 2012 Q3 2012-01-01 2012-09-30
652,000 2013-11-05 10-Q 2013 Q3 2012-01-01 2012-09-30
1,154,000 2012-10-24 10-Q 2012 Q3 2012-07-01 2012-09-30
1,154,000 2013-11-05 10-Q 2013 Q3 2012-07-01 2012-09-30 CY2012Q3
990,000 2013-02-15 10-K 2012 FY 2012-01-01 2012-12-31
990,000 2014-02-13 10-K 2013 FY 2012-01-01 2012-12-31
990,000 2015-02-12 10-K 2014 FY 2012-01-01 2012-12-31 CY2012
1,890,000 2013-05-03 10-Q 2013 Q1 2013-01-01 2013-03-31
1,890,000 2014-05-08 10-Q 2014 Q1 2013-01-01 2013-03-31 CY2013Q1
2,337,000 2013-08-06 10-Q 2013 Q2 2013-01-01 2013-06-30
2,337,000 2014-08-05 10-Q 2014 Q2 2013-01-01 2013-06-30
2,645,000 2013-08-06 10-Q 2013 Q2 2013-04-01 2013-06-30
2,645,000 2014-08-05 10-Q 2014 Q2 2013-04-01 2013-06-30 CY2013Q2
2,556,000 2013-11-05 10-Q 2013 Q3 2013-01-01 2013-09-30
2,556,000 2014-11-04 10-Q 2014 Q3 2013-01-01 2013-09-30
2,885,000 2013-11-05 10-Q 2013 Q3 2013-07-01 2013-09-30
2,885,000 2014-11-04 10-Q 2014 Q3 2013-07-01 2013-09-30 CY2013Q3
2,707,000 2014-02-13 10-K 2013 FY 2013-01-01 2013-12-31
2,707,000 2015-02-12 10-K 2014 FY 2013-01-01 2013-12-31
2,707,000 2016-02-11 10-K 2015 FY 2013-01-01 2013-12-31 CY2013
3,162,000 2014-05-08 10-Q 2014 Q1 2014-01-01 2014-03-31
3,162,000 2015-05-07 10-Q 2015 Q1 2014-01-01 2014-03-31 CY2014Q1
3,018,000 2014-08-05 10-Q 2014 Q2 2014-01-01 2014-06-30
3,018,000 2015-08-04 10-Q 2015 Q2 2014-01-01 2014-06-30
2,877,000 2014-08-05 10-Q 2014 Q2 2014-04-01 2014-06-30
2,877,000 2015-08-04 10-Q 2015 Q2 2014-04-01 2014-06-30 CY2014Q2
2,950,000 2014-11-04 10-Q 2014 Q3 2014-01-01 2014-09-30
2,950,000 2015-11-04 10-Q 2015 Q3 2014-01-01 2014-09-30
2,787,000 2014-11-04 10-Q 2014 Q3 2014-07-01 2014-09-30
2,787,000 2015-11-04 10-Q 2015 Q3 2014-07-01 2014-09-30 CY2014Q3
2,936,000 2015-02-12 10-K 2014 FY 2014-01-01 2014-12-31
2,936,000 2016-02-11 10-K 2015 FY 2014-01-01 2014-12-31
2,936,000 2017-02-09 10-K 2016 FY 2014-01-01 2014-12-31 CY2014
2,512,000 2015-05-07 10-Q 2015 Q1 2015-01-01 2015-03-31
2,512,000 2016-05-05 10-Q 2016 Q1 2015-01-01 2015-03-31 CY2015Q1
2,492,000 2015-08-04 10-Q 2015 Q2 2015-01-01 2015-06-30
2,492,000 2016-08-04 10-Q 2016 Q2 2015-01-01 2015-06-30
2,461,000 2015-08-04 10-Q 2015 Q2 2015-04-01 2015-06-30
2,461,000 2016-08-04 10-Q 2016 Q2 2015-04-01 2015-06-30 CY2015Q2
2,395,000 2015-11-04 10-Q 2015 Q3 2015-01-01 2015-09-30
2,395,000 2016-11-04 10-Q 2016 Q3 2015-01-01 2015-09-30
2,175,000 2015-11-04 10-Q 2015 Q3 2015-07-01 2015-09-30
2,175,000 2016-11-04 10-Q 2016 Q3 2015-07-01 2015-09-30 CY2015Q3
2,246,000 2016-02-11 10-K 2015 FY 2015-01-01 2015-12-31
2,246,000 2017-02-09 10-K 2016 FY 2015-01-01 2015-12-31
2,246,000 2018-02-08 10-K 2017 FY 2015-01-01 2015-12-31 CY2015
1,278,000 2016-05-05 10-Q 2016 Q1 2016-01-01 2016-03-31
1,278,000 2017-05-04 10-Q 2017 Q1 2016-01-01 2016-03-31 CY2016Q1
1,130,000 2016-08-04 10-Q 2016 Q2 2016-01-01 2016-06-30
1,130,000 2017-08-03 10-Q 2017 Q2 2016-01-01 2016-06-30
984,000 2016-08-04 10-Q 2016 Q2 2016-04-01 2016-06-30
984,000 2017-08-03 10-Q 2017 Q2 2016-04-01 2016-06-30 CY2016Q2
1,086,000 2016-11-04 10-Q 2016 Q3 2016-01-01 2016-09-30
1,086,000 2017-11-08 10-Q 2017 Q3 2016-01-01 2016-09-30
998,000 2016-11-04 10-Q 2016 Q3 2016-07-01 2016-09-30
998,000 2017-11-08 10-Q 2017 Q3 2016-07-01 2016-09-30 CY2016Q3
936,000 2017-02-09 10-K 2016 FY 2016-01-01 2016-12-31
936,000 2018-02-08 10-K 2017 FY 2016-01-01 2016-12-31
900,000 2019-02-07 10-K 2018 FY 2016-01-01 2016-12-31 CY2016
0 2017-05-04 10-Q 2017 Q1 2017-01-01 2017-03-31 CY2017Q1
0 2017-08-03 10-Q 2017 Q2 2017-01-01 2017-06-30
0 2017-08-03 10-Q 2017 Q2 2017-04-01 2017-06-30 CY2017Q2
0 2017-11-08 10-Q 2017 Q3 2017-01-01 2017-09-30
0 2017-11-08 10-Q 2017 Q3 2017-07-01 2017-09-30 CY2017Q3
0 2018-02-08 10-K 2017 FY 2017-01-01 2017-12-31
0 2019-02-07 10-K 2018 FY 2017-01-01 2017-12-31 CY2017
0 2019-02-07 10-K 2018 FY 2018-01-01 2018-12-31 CY2018

SEC Filings Explorer

Formalu provides easy access to SEC filings and reporting data

Explore SEC Data

Most Recent Filings

2000 most recent SEC filings for the current official filing date

Recent Filings

Aggregated Data

SEC filing data for all companies grouped by time and accounting terms

Aggregate Reports

Formalu's Securities and Exchange Commission Page

SEC forms, contact information and locations

SEC Forms & Info